Вы находитесь на странице: 1из 17

UTOPIA

CINDY LIM XING-RU 232192


NG SHU WEI 232754
TEOH CHIEN WEI 232918
HO CHUN HOONG 234082
LIM WEI QIAN 234435
Company Backgrounds
Established in 1975
Offering wide range of
complementary medicines,
medicated tonic, beauty,
healthcare products and clinical
services.
First traditional healthcare company
listed on Bursa Malaysia Securities
Berhad since 1996
Business model: Direct selling in Multi
Level Marketing
Vision

We aim to become the premier


healthcare company in Malaysia and
thereby bringing the greatest value and
pride to our customers, business partners,
employees and shareholders.
Mission

We are committed to promoting


healthcare culture and improving human's
well-being.
Corporate Values
Corporate Structure

Wholesale
Multi Level Marketing
Retailing
Manufacturing
Others
(Pharmaceutical,
Chinese Consulting
Clinics)
Issues and Problems
Uninformed and negative scepticisms for the
traditional medicine
Lacking of new existing new products
Intense price competition
Economic downturn
Threat of substitute product
SWOT ANALYSIS (STRENGTH)

High and
Supportive
stable
distributors
income

Control over
Bumiputra
market
CONT. (WEAKNESSES)

Small market Low barrier of


capitalization market entry

Lack of belief
Homogeneous
in Chinese
product
medicine
CONT. (OPPORTUNITIES)

Possible of
Government going
incentives international
market

Possible JV as
going
international
CONT. (THREATS)

Intense Government
competition regulation
TOWS Analysis of Hai-O
External Opportunity

Internal Strength Internal weakness


 Strong Bumiputera-oriented MLM  Negative side effect of traditional
structure medication
 Growing demands for traditional and  Growing demands for traditional and
herbal medicines herbal medicines
 Government incentive and research  Lack of new exciting products
grants for R&D
 Government incentive and research
 Strong foothold in China grants for R&D
 Expansion overseas Internal Weakness  Future changes in consumer
preference and demand will impact
inventory
TOWS Analysis of Hai-O
External Threat

Internal Strength Internal Weakness


 Strong Bumiputera-oriented MLM  Negative side effect of traditional
structure medication
 New market entrance  New market entrance
 Own pharmaceutical manufacturing  Lack of new exciting products
capacity
 Weaker RM impact in imported
 Weaker RM impact on imported products
products
 Future changes in consumer
 Strong foothold in China preference and demand will impact
inventory
General Forces (PEST ANALYSIS)

1. POLITICAL
- Exposed to pre- election effects
- Internal bickering within the ruling coalition
2. ECONOMICAL
- Rising demands from local and international users
3. SOCIALOGICAL
- Shift towards healthy lifestyle among Malaysians
4. TECHNOLOGICAL
- Improvement and extended in pharmaceutical and biotechnology
segment
5 FORCES

Bargaining power of buyer


•Intense competition
•Low switching cost
•Increasing demand
Bargaining power of supplier
•Homogeneous product
•Sources of supplier from oversea market
CONT.

THREAT OF SUBSTITUTE
•Modern medical specialty
•Similarity of substitute

THREAT OF NEW ENTRANCE


•Unable to achieve economies scale
•Low startup cost
CONT.

RIVALRY AMONG EXISTING


COMPETITORS
•Aggressive competitions
•Low product differentiations
•Size of competitors